The global VNA market is poised to reach $335 million by 2018, at a healthy double-digit CAGR; whereas, the PACS market is growing at a steady CAGR of 5.8%, to reach $4.3 billion by 2018.
Dallas, TX -- (SBWIRE) -- 03/03/2014 -- The "Vendor Neutral Archive Market & PACS Market - VNA [On-premise Software, Hybrid & Cloud, Multi-Department & Multi-Site VNA] & Picture Archiving and Communication System [Enterprise, Cardiology & Radiology] - Global Forecast to 2018" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.
Browse 54 market data tables and 48 figures spread through 215 pages and in-depth TOC on "Vendor Neutral Archive Market & PACS Market".
Early buyers will receive 10% customization on this report@ http://www.marketsandmarkets.com/requestCustomization.asp?id=1255
This report studies the global VNA and PACS market over the forecast period of 2013 to 2018. The global VNA market is estimated at $165.3 million in 2013 and is poised to reach $335.4 million by 2018, at a CAGR of 15.2%.
Ask for a free copy of PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=1255
At present, the vendor neutral archive and picture archiving and communication system (PACS) markets form indispensable segments of the imaging informatics market. The overall market (VNA and PACS) comprises of VNA software solutions as well as departmental and enterprise PACS.
Departmental PACS currently dominates the overall VNA and PACS market with around 86.5% of the total revenue contribution. However, this market is a considerably mature market generating most of the revenues from PACS replacements. Hence, the market is expected to witness a stable CAGR of 5.2% from 2013 to 2018. Enterprise PACS, on the other hand, is growing faster than departmental PACS and is expected to reach $510 million by 2018, at an almost double CAGR.
Owing to the growing popularity of vendor neutral archive solutions, the VNA market is currently in the growth phase of its product lifecycle. The market is characterized by several inter-firm partnerships to deliver best-of-breed solutions to healthcare providers. In addition, development of products that enable the integration of VNAs with EHRs and their subsequent launch in the market is a growing trend.
The major driving factors of the vendor neutral archive market include the need for centralized storage of standard-compliant imaging data, government initiatives that favor the use of advanced imaging information systems, and technology and cost-related benefits. On the other hand, lack of an established definition of VNA resulting in confusion and data insecurity (breaches) is an issue that restricts market growth. Cloud-based VNAs, emerging markets, and patient-focused systems promise high-growth opportunities in the global market.
In 2013, North America contributes the maximum share to both VNA and PACS markets, with shares of 64% and 48%, respectively. U.K., Germany, and France contribute largely to the European VNA and PACS market, whereas the Asia-Pacific region represents the most promising region owing to the nation and state-wide healthcare IT policies in Australia, China, and Japan. Although the penetration of VNAs in the RoW region is low, the PACS technology is now widely adopted in Latin America and the Middle East.
Key companies in the VNA and PACS market include Acuo Technologies (U.S.), Agfa HealthCare (Belgium), BridgeHead Software (U.K.), Carestream Health (U.S.), Dell, Inc. (U.S.), GE Healthcare (U.K.), Fujifilm Corporation (Japan), Merge Health (U.S.), McKesson Corporation (U.S.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), and TeraMedica (U.S.).
Browse Related Reports:
Healthcare IT Market By Application [Provider IT (EMR, PACS, CPOE, RIS, CDSS, RCM, Claims Management, Payroll), Payer IT (CRM, Fraud Detection)], Delivery Mode (On-Premises, Web-Based Services & Cloud Computing) & Component – Global Forecasts to 2017
Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dentritic Vaccines And By Indications - Infectious Diseases, Cancer, Allergy, Diabetes, Cardiovascular Disease With Market Landscape Analysis - Global Forecasts To 2022
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/healthcareit
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets